Abstract
It is a dainty, fern-like, annual herb, found in Persia, Nepal , and as a weed in many other countries. Both F. officinalis and F. parviflora are known as Shahatra in India and used interchangeably. Greeks and Romans were aware of this plant for its diuretic and alterative properties. Dioscorides called it Kapnos and Pliny named it Fumaria from Fumus (smoke), because the plant irritates the eyes like smoke. Ibn al-Baitar mentioned its Greek names as Fasaniyus and Faqeez with reference to Dioscorides. Highly esteemed by generations of herbalists, fumitory is a superb liver tonic—as befits a plant ruled by Jupiter. A good digestive herb, highly recommended for all hepatic ailments, from simple biliousness to chronic malfunctioning of the liver; it cures nausea, vomiting and painful cramps and also dispels lassitude and improves concentration. In the Ayurvedic classic texts of Charaka and Sushruta, Fumaria parviflora is recommended for the treatment of fevers, blood disorders, chronic skin diseases, urinary diseases and cough. Indian fumitory (Fumaria indica) is known as Parpat in Ayurveda and traditionally used to calm brain. In Germany, F. officinalis is approved for “colicky pain affecting the gallbladder and biliary system, together with the gastrointestinal tract.” It contains isoquinoline alkaloids, potassium salts, and tannins, and is a major source of fumaric acid. Aqueous and ethanol extracts of leaves of F. parviflora exhibited significant anti-inflammatory activity and reduced levels of TNF-α, IL-6 and IL-1. Pretreatment of rats with aqueous-methanol extract significantly prevented APAP-hepatotoxicity, but failed to prevent CCI4-induced liver damage. Coadministration of ethanol extract prevented lead-induced testicular toxicity in male rats. In a double-blind, RCT, fumitory was devoid of any significant therapeutic benefit over placebo in German patients with IBS.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Brinkhaus B, Hentschel C, Von Keudell C, et al. Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial. Scand J Gastroenterol. 2005;40:936–43.
Chlebek J, Novák Z, Kassemová D et al. Isoquinoline alkaloids from Fumaria officinalis L. and their biological activities related to Alzheimer’s disease. Chem Biodivers. 2016;13:91–9.
Dorostghoal M, Seyyednejad SM, Jabari A. Protective effects of Fumaria parviflora L. on lead-induced testicular toxicity in male rats. Andrologia. 2014;46:437–46.
Ferreira JF, Peaden P, Keiser J. In vitro trematocidal effects of crude alcoholic extracts of Artemisia annua, A. absinthium, Asimina triloba, and Fumaria officinalis: trematocidal plant alcoholic extracts. Parasitol Res. 2011;109:1585–92.
Gilani AH, Janbaz KH, Akhtar MS. Selective protective effect of an extract from Fumaria parviflora on paracetamol-induced hepatotoxicity. Gen Pharmacol. 1996;27:979–83.
Hentschel C, Dressler S, Hahn EG. Fumaria officinalis (fumitory)—clinical applications. Fortschr Med. 1995;113:291–2 (Review, German).
Hermansson J, Sandberg F. Alkaloids of Fumaria officinalis. Acta Pharmaceut Suecica. 1973;10:520–2.
Jameel M, Ali A, Ali M. New phytoconstituents from the aerial parts of Fumaria parviflora Lam. J Adv Pharm Technol Res. 2014;5:64–9.
Jameel M, Islamuddin M, Ali A, Afrin F, Ali M. Isolation, characterization and antimicrobial evaluation of a novel compound N-octacosan 7β ol, from Fumaria parviflora Lam. BMC Complement Altern Med. 2014;14:98.
Najeeb-ur-Rehman, Mehmood MH, Al-Rehaily AJ, Mothana RA, Gilani AH. Species and tissue-specificity of prokinetic, laxative and spasmodic effects of Fumaria parviflora. BMC Complement Altern Med. 2012;12:16.
Orhana I, Ozçelik B, Karaoğlu T, Sener B. Antiviral and antimicrobial profiles of selected isoquinoline alkaloids from Fumaria and Corydalis species. Z Naturforsch. 2007;62:19–26.
Popova ME, Simánek V, Dolejs L, Smysl B, Preininger V. Alkaloids from Fumaria parviflora and F. kralikii. Planta Med. 1982;45:120–2.
Rizvi W, Fayazuddin M, Singh O, et al. Anti-inflammatory effect of Fumaria parviflora leaves based on TNF-α, IL-1, IL-6 and antioxidant potential. Avicenna J Phytomed. 2017;7:37–45.
Sengul M, Yildiz H, Gungor N, et al. Total phenolic content, antioxidant and antimicrobial activities of some medicinal plants. Pak J Pharm Sci. 2009;22:102–6.
Singh GK, Rai G, Chatterjee SS, Kumar V. Effects of ethanolic extract of Fumaria indica L. on rat cognitive dysfunctions. Ayu. 2013;34:421–9.
Sturm S, Strasser EM, Stuppner H. Quantification of Fumaria officinalis isoquinoline alkaloids by nonaqueous capillary electrophoresis-electrospray ion trap mass spectrometry. J Chromatogr A. 2006;1112:331–8.
Válka I, Walterová D, Popova ME, Preininger V, Simánek V. Separation and quantification of some alkaloids from Fumaria parviflora by capillary isotachophoresis1. Planta Med. 1985;51:319–22.
Vrba J, Vrublova E, Modriansky M, Ulrichova J. Protopine and allocryptopine increase mRNA levels of cytochromes P450 1A in human hepatocytes and HepG2 cells independently of AhR. Toxicol Lett. 2011;203:135–41.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Akbar, S. (2020). Fumaria officinalis L. (F. parviflora Lam.) (Papaveraceae). In: Handbook of 200 Medicinal Plants. Springer, Cham. https://doi.org/10.1007/978-3-030-16807-0_101
Download citation
DOI: https://doi.org/10.1007/978-3-030-16807-0_101
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16806-3
Online ISBN: 978-3-030-16807-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)